Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
Greenberger
Paul A
PA
Ballow
Mark
M
Casale
Thomas B
TB
Platts-Mills
Thomas A E
TA
Sampson
Hugh A
HA
D000286:Administration, Sublingual; D000485:Allergens / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000574:American Medical Association; D003888:Desensitization, Immunologic / Q000379:methods* / Q000639:trends; D006801:Humans; D007279:Injections, Subcutaneous; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D000485:Allergens